Answers are grounded in this paper and cite their sources.
Malaria is a disease of public health importance in many parts of the world. Currently, there is no effective way to eradicate malaria, so developing safe, efficient, and cost-effective vaccines against this disease remains an important goal. Current research on malaria vaccines is focused on developing vaccines against pre-erythrocytic stage parasites and blood-stage parasites or on developing a transmission-blocking vaccine. Here, we briefly describe the progress made towards a vaccine againstPlasmodium falciparum, the most pathogenic of the malaria parasite species to infect humans.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: